Atlas Trials

A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia

Clinical trial NCT01493726 · COMPLETED

Trial details

NCT number
NCT01493726
Sponsor
Alkermes, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2011-12-01
Primary completion
2013-06-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.